Plasma fibronectin in psoriatic arthritis subgroups

Area of Science:

• Biochemistry
• Immunology
• Rheumatology

Background:

• Psoriatic Arthritis (PA) is a complex inflammatory condition.
• Soluble plasma Fibronectin (pFn) is a protein involved in tissue repair.
• The role of pFn in PA pathogenesis is not fully understood.

Purpose of the Study:

• To investigate plasma Fibronectin (pFn) levels in patients with Psoriatic Arthritis (PA).
• To correlate pFn concentrations with disease severity, duration, and inflammatory markers in PA.
• To evaluate the potential role of pFn as a marker in PA.

Main Methods:

• Plasma samples from 38 PA patients across five subgroups were analyzed for pFn.
• pFn concentrations were compared to a healthy control group.
• Correlations were performed between pFn levels and clinical parameters (psoriasis/arthritis severity and duration), biohumoral markers (ESR, CRP, sCu, sFe, Hb, uric acid), and HLA typing.

Main Results:

• Mean total pFn concentration in PA patients was significantly higher (453.03 µg/ml ± 142.83 SD) than in controls (p < 0.01).
• No specific correlation was found between pFn levels and disease specificity.
• pFn concentrations showed potential as a general marker for connective tissue response in severe PA cases.

Conclusions:

• Plasma Fibronectin (pFn) is significantly elevated in Psoriatic Arthritis (PA) patients.
• pFn does not appear to be a disease-specific marker for PA.
• Elevated pFn may serve as a general indicator of connective tissue repair in severe PA, rather than an acute phase reactant.